Healthcare DIVE February 14, 2024
High interest rates and new regulations could be driving the slowdown, according to a report by the Private Equity Stakeholder Project.
Dive Brief:
- Private equity deals in Medicare Advantage have declined since 2021, likely due to high interest rates and a stricter regulatory environment, according to a report published Tuesday by the Private Equity Stakeholder Project.
- There was a spike in PE investment between 2019 and 2021, with a dip in 2020, possibly due to the COVID-19 pandemic, according to the analysis. More than half of the deals during that period involved insurance brokerage and marketing firms.
- But there were 66% fewer MA deals last year compared with 2022, and 79% fewer deals than in 2021, according...
Today's Sponsors
Today's Sponsor